Lui Wai Yan Vivian
Associate Professor
School of Biomedical Sciences
The Chinese University of Hong Kong
Hong Kong
Biography
Dr. LUI Wai Yan Vivian is affiliated to School of Biomedical Sciences, CUHK , where Dr. LUI Wai Yan Vivian is currently working as Associate Professor. Dr. LUI Wai Yan Vivian has numerous publications within the specialty and published in reputed national and international peer-reviewed journals. Dr. LUI Wai Yan Vivian is actively associated with different national and international societies and academies. Dr. LUI Wai Yan Vivian gain recognition among the honourable subject experts with the contributions made. Dr. LUI Wai Yan Vivian is been appreciated by several reputed awards and funding support. Dr. LUI Wai Yan Vivian major research interest is in studies related to Integrated Cancer Genomic-Proteomic bioinformatics for therapeutics and translational research,Functional genomics and platform development for druggable mutations and driver mutations in human oncogenesis,Molecular mechanisms of mutation-based drug sensitivity for targeted therapies,Mechanisms of viral-mediated oncogenesis in aerodigestive tract cancers and Nasopharyngeal cancer.
Research Interest
Integrated Cancer Genomic-Proteomic bioinformatics for therapeutics and translational research,Functional genomics and platform development for druggable mutations and driver mutations in human oncogenesis,Molecular mechanisms of mutation-based drug sensitivity for targeted therapies,Mechanisms of viral-mediated oncogenesis in aerodigestive tract cancers and Nasopharyngeal cancer.
Publications
-
Li, H., Wheeler, S., Park, Y., Ju, Z., Thomas, S.M., Fichera, M., Egloff, A.M., Lui. V.W., Duvvuri, U., Bauman, J.E., Mills, G.B. and Grandis, J.R. (2016). Proteomic characterization of head and neck cancer patient-derived xenografts. Mol. Cancer Res., 14(3), 278-286.
-
Wen, Y., Li, H., Zeng, Y., Wen, W., Pendleton, K.P., Lui, V.W., Egloff, A.M. and Grandis, J.R. (2016). MAPK1(E322K) mutation increased head and neck suamous cell carcinoma sensitivity to erlotinib through enhanced secretion of amphiregulin. Oncotarget, 7(17), 23300-23311.
-
Hedberg, M.L., Goh, G., Chiosea, S.I., Bauman, J.E., Freilino, M.L., Zeng, Y., Wang, L., Diergaarde, B.B., Gooding, W.E., Lui, V.W., Herbst, R.S., Lifton, R.P. and Grandis, J.R. (2016). The genetic landscape of head and neck cancer recurrence and metastasis. J. Clin. Investigation, 126(1), 169-180.
